Our Philadelphia clinics provide a non-invasive, evidence-based approach for residents seeking relief from major depressive disorder (MDD) and treatment-resistant depression (TRD). Unlike traditional clinical settings, we offer Transcranial Magnetic Stimulation (TMS) in a medically supervised, comfortable environment. As an FDA-approved treatment, TMS is designed for adults who have not found relief through standard oral antidepressants or who prefer a non-medication alternative. This allows patients from Center City, University City, and surrounding communities to access brain stimulation treatment without hospitalization or systemic side effects.
Clinical teams in Philadelphia focus on achieving symptom relief by stimulating targeted brain regions associated with mood regulation. While traditional antidepressants can take weeks or months to work, TMS often begins to improve depressive symptoms within the first 2-4 weeks of treatment. Our facilities are strategically located throughout the Philadelphia metro area to be easily accessible for those living and working in this historic and vibrant city. During your initial consultation, we provide a detailed overview of how magnetic stimulation technology targets specific neural circuits to restore healthy mood function.
Our Philadelphia clinics maintain clinical protocols and standards established by the FDA and psychiatric associations. Every treatment session is overseen by qualified TMS technicians and psychiatric professionals who monitor your progress and adjust treatment parameters as needed. TMS is well-tolerated, and most patients experience only mild scalp discomfort during treatment sessions.
Clinical teams in Philadelphia serve patients from convenient locations in Center City, University City, and surrounding accessible neighborhoods. Because TMS sessions are outpatient procedures, our scheduling is designed to work around professional and family commitments, allowing you to continue your daily activities while receiving treatment.
TMS is FDA-approved and has been extensively studied. Clinical research shows that TMS can help improve depressive symptoms in many patients, particularly those who have not responded to antidepressants. Individual results vary, and your clinical team will discuss what to expect during your initial consultation.
Yes, our certified Philadelphia clinics serve as specialized hubs for residents across the metro area, offering access to TMS technology in convenient locations in Center City, University City, and surrounding communities.
The cost varies based on your individualized treatment plan and number of sessions required. Most major Pennsylvania insurance providers, including Aetna, Blue Cross Blue Shield of Pennsylvania, UnitedHealthcare, and Cigna, cover TMS for depression. Our staff will help you verify coverage and explore patient assistance programs to make treatment accessible.
Clinical teams typically recommend a standard course of 30 sessions over 4-6 weeks. Sessions are usually scheduled 5 days per week and last approximately 30-40 minutes each. Some patients may benefit from additional sessions based on their individual response.
Our Philadelphia facilities primarily treat adults with Major Depressive Disorder (MDD) and Treatment-Resistant Depression (TRD). TMS may also be considered for other conditions as determined by our clinical team during your evaluation.
While a referral is not always required, we do recommend an initial consultation with one of our psychiatrists to assess whether TMS is appropriate for your specific condition and psychiatric history. This ensures you receive the most effective treatment plan tailored to your needs.
"*" indicates required fields
